AU2001247543A1 - Bispecific molecules cross-linking itim and itam for therapy of allergies - Google Patents

Bispecific molecules cross-linking itim and itam for therapy of allergies

Info

Publication number
AU2001247543A1
AU2001247543A1 AU2001247543A AU2001247543A AU2001247543A1 AU 2001247543 A1 AU2001247543 A1 AU 2001247543A1 AU 2001247543 A AU2001247543 A AU 2001247543A AU 2001247543 A AU2001247543 A AU 2001247543A AU 2001247543 A1 AU2001247543 A1 AU 2001247543A1
Authority
AU
Australia
Prior art keywords
itim
itam
allergies
therapy
linking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247543A
Inventor
Sunny Tam
David Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanox Inc
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of AU2001247543A1 publication Critical patent/AU2001247543A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/626—Diabody or triabody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001247543A 2001-03-16 2001-03-16 Bispecific molecules cross-linking itim and itam for therapy of allergies Abandoned AU2001247543A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/008671 WO2003064662A1 (en) 2001-03-16 2001-03-16 Bispecific molecules cross-linking itim and itam for therapy of allergies

Publications (1)

Publication Number Publication Date
AU2001247543A1 true AU2001247543A1 (en) 2003-09-02

Family

ID=27658024

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247543A Abandoned AU2001247543A1 (en) 2001-03-16 2001-03-16 Bispecific molecules cross-linking itim and itam for therapy of allergies

Country Status (2)

Country Link
AU (1) AU2001247543A1 (en)
WO (1) WO2003064662A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077282A1 (en) 2001-10-12 2003-04-24 Bigler Michael Eric Use of bispecific antibodies to regulate immune responses
US8198427B1 (en) 2002-11-14 2012-06-12 Dharmacon, Inc. SiRNA targeting catenin, beta-1 (CTNNB1)
WO2005095460A2 (en) 2004-03-30 2005-10-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof
WO2014188423A1 (en) 2013-05-21 2014-11-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Treatment of mast cell related pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11501622A (en) * 1995-02-28 1999-02-09 ナショナル ジューイッシュ センター フォー イミュノロジー アンド レスピラトリー メディスン Peptidyl compounds containing ITIM motif that regulate hematopoietic function and their use
WO1998009638A1 (en) * 1996-09-06 1998-03-12 The Brigham And Women's Hospital, Inc. INHIBITION OF MAST CELL ACTIVATION BY gp49-BASED MECHANISMS AND REAGENTS
EP0861891A1 (en) * 1996-12-31 1998-09-02 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compounds for modulating cell negative regulations and biological applications thereof

Also Published As

Publication number Publication date
WO2003064662A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
EP1239630A3 (en) Method and apparatus for increasing the security of wireless data services
AU2002357735A1 (en) Electronic door viewer and method of use
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2002355271A1 (en) Product for treating contaminated fluids and method of making and using the same
AU2002329570A1 (en) Method of monitoring neuroprotective treatment
AU2003275254A1 (en) Targeted cd1d molecules
AU2002326580A1 (en) Computer-based methods of designing molecules
SG119165A1 (en) Display apparatus and method of manufacturing the same
AU1727500A (en) Bispecific molecules cross-linking itim and itam for therapy
AU2003285523A1 (en) Uses of optical projection tomography methods and apparatus
AU2001247543A1 (en) Bispecific molecules cross-linking itim and itam for therapy of allergies
AUPR535101A0 (en) Novel therapeutic molecules
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2002244575A1 (en) Individualization of therapy with antidepressants
AU2003255804A1 (en) Comparison of molecules using field points
AU2002361488A1 (en) Field and background of the invention
AU2002352374A1 (en) Apparatus and method for the continuous photolytic treatment of an effluent
AU2002349818A1 (en) Method and device for determining the minimum erythemal dose
EP1270383A3 (en) Elastic crawler and method of producing the same
AU2002366507A1 (en) Method and apparatus for the reduction of electromagnetic radiation from display screens
AU2002338119A1 (en) The coding method, application method and coding device of extended frequency multiaddress
AUPR463401A0 (en) Therapeutic molecules and methods - 2
AUPR421601A0 (en) Therapeutic molecules and methods - 1B
AU2002248789A1 (en) Activated biregional fibers and method for the manufacture of them
AUPR648901A0 (en) Novel therapeutic molecules and uses therefor